-

2 Day Virtual Biological Evaluation of Medical Devices Training Course: Ensure Compliance with the ISO 10993 Series of Standards for the Biological Evaluation of Medical Devices (Jan 21st-22nd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Biological Evaluation of Medical Devices Training Course (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's offering.

Ensure compliance with the ISO 10993 series of standards for the biological evaluation of medical devices, as it is well-established and expected by regulatory authorities worldwide.

In the European Union, compliance with these standards is crucial for meeting the essential safety requirements outlined in the Medical Device Regulation (MDR). Understanding and implementing a comprehensive risk management strategy for biological safety is therefore paramount.

This seminar offers essential guidance on effectively utilising the ISO 10993 standards and integrating a robust risk management approach into the biological evaluation process of medical devices. Participants will have ample opportunity to engage in interactive discussions with industry experts, gaining practical insights and best practices.

Attendees will emerge equipped with the knowledge and tools necessary to navigate regulatory requirements, mitigate risks, and ensure the safety and efficacy of medical devices in compliance with global standards.

Benefits of attending

  • Understand biological risk management
  • Clarify the requirements of ISO 10993-1
  • Learn what endpoints need to be addressed in a biological risk assessment
  • Establish how much chemical characterisation is necessary
  • Explore the FDA's approach to ISO 10993
  • Comprehend the Medical Device Directive (MDD) safety requirements vs the Medical Device Regulation (MDR) safety requirements
  • Recognise how extractables and leachables impact medical device safety
  • Discuss the Japanese and Chinese requirements

Certifications:

  • CPD: 12 hours for your records
  • Certificate of completion

Who Should Attend:

  • Regulatory affairs
  • R&D
  • Product safety/toxicology
  • Analytical chemistry
  • Risk assessment and risk management
  • Materials research and evaluation

It will also be of interest to regulatory authorities, Notified Bodies and CROs supporting the medical device industry.

For more information about this training visit https://www.researchandmarkets.com/r/btlank

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

U.S. Countertop Market Intelligence Report 2025-2030: Emerging Trend Reveals that Bold Patterns and Sintered Stones Shine - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "U.S. Countertop Market Research Report 2025-2030" has been added to ResearchAndMarkets.com's offering. The U.S. countertop market, valued at USD 28.65 billion in 2024, is projected to reach USD 32.44 billion by 2030, growing at a CAGR of 2.09%. This growth is fueled by the burgeoning interest in bold countertop patterns, sintered stone, high-performance porcelain, and the demand for smart countertops. An uptick in the use of ultra-compact and lightweight materials,...

CAR T-Cell Therapy for the Multiple Myeloma Market, 2025-2035: Extensive Data on Products, End Users, Regions and Companies - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "CAR T-Cell Therapy for Multiple Myeloma Market - A Global and Regional Analysis: Focus on Product, End User, and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering. The chimeric antigen receptor (CAR) T-cell therapy has emerged as a groundbreaking treatment modality, offering new hope for patients with relapsed or refractory multiple myeloma (RRMM). Building upon traditional treatments such as autologous stem cell transpl...

Fallopian Tube Cancer Market Analysis and Global Business Opportunities, 2025-2035 - Targeted Therapies Transform the Fallopian Tube Cancer Treatment Landscape - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Fallopian Tube Cancer Market - A Global and Regional Analysis: Focus on Type, Treatment Type, End User, and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering. The global fallopian tube cancer market is being driven by several key factors. Rising awareness and early screening initiatives, supported by public health campaigns and improved diagnostic imaging technologies, are enabling earlier detection of gynaecologic cance...
Back to Newsroom